stella
beta
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects — Stella
Recruiting
Back to Photosensitivity trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Wright State Physicians, Fairborn, Ohio
View full record on ClinicalTrials.gov